SOUTH SAN FRANCISCO, Calif., Jan. 30, 2019-- Portola Pharmaceuticals, Inc. ® today announced that full results from the Company' s ANNEXA-4 study of.
Wednesday 30 January 2019
Portola Pharmaceuticals to Present Full Results from the ANNEXA-4 Study of Andexxa During a Late-Breaking Oral Presentation at the International Stroke Conference 2019 - Nasdaq
Portola Pharmaceuticals to Present Full Results from the ANNEXA-4 Study of Andexxa During a Late-Breaking Oral Presentation at the International Stroke Conference 2019 Nasdaq
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment